Statistik Asas
| LEI | 549300NY2WTA02KF7L12 |
| CIK | 1839341 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Core Scientific, Inc. - Equity Warrant
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| September 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☑ Check the appropriate box: ☑ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| August 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001 |
|
| August 8, 2025 |
Core Scientific Announces Fiscal Second Quarter 2025 Results Core Scientific Announces Fiscal Second Quarter 2025 Results AUSTIN, Texas, August 8, 2025 - Core Scientific, Inc. |
|
| August 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fi |
|
| August 7, 2025 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement ¨ Definitive Additional Materials þ Soliciting Material Under Rule 14a-12 Core Scientific, Inc. |
|
| July 14, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 14, 2025 The following communication was posted by CoreWeave, Inc. on its LinkedIn account on July 11, 2025 in connection with CoreWea |
|
| July 14, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 14, 2025 The following communication was posted by CoreWeave, Inc. on its X account on July 11, 2025 in connection with CoreWeave’s pr |
|
| July 14, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 14, 2025 The following is a transcript of an interview with Michael Intrator, Chief Executive Officer of CoreWeave, Inc. on July 8, 20 |
|
| July 9, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 9, 2025 The following message was distributed by executive officers and founders of CoreWeave, Inc. to employees of Core Scientific, I |
|
| July 9, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 9, 2025 The following communication was posted on CoreWeave, Inc.’s LinkedIn account on July 8, 2025 in connection with CoreWeave’s pr |
|
| July 8, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 7, 2025 The following communication was posted on LinkedIn by Michael Intrator, Chief Executive Officer of CoreWeave, Inc., on July7, |
|
| July 8, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 7, 2025 The following communication was distributed by CoreWeave, Inc. to its employees on July 7, 2025 in connection with CoreWeave's |
|
| July 8, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 7, 2025 The following communication was posted on LinkedIn by Michael Intrator, Chief Executive Officer of CoreWeave, Inc., on July7, |
|
| July 8, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 8, 2025 The following communication was posted on CoreWeave, Inc.’s X account on July 8, 2025 in connection with CoreWeave’s proposed |
|
| July 8, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 8, 2025 The following is a transcript of an interview with Michael Intrator, Chief Executive Officer of CoreWeave, Inc. on July 7, 202 |
|
| July 7, 2025 |
425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| July 7, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc. (Commission File No.: 001-40046) Date: July 7, 2025 The following presentation was posted on CoreWeave, Inc.'s website on July 7, 2025 in connection with CoreWeave's proposed acquis |
|
| July 7, 2025 |
Filed by Core Scientific, Inc. Filed by Core Scientific, Inc. (Commission File No.: 001-40046) Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Core Scientific, Inc. (Commission File No.: 001-40046) The following communication was made available by Core Scientific, Inc. to its employees on July 7, 2025. To: All Core Scientif |
|
| July 7, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 7, 2025 The following blog was posted by Michael Intrator, Chief Executive Officer of CoreWeave, Inc., on CoreWeave’s website on July |
|
| July 7, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 7, 2025 The following is a transcript of an investor call held by CoreWeave, Inc. on July 7, 2025. The speakers are identified therein |
|
| July 7, 2025 |
Filed by CoreWeave, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Core Scientific, Inc./tx (Commission File No.: 001-40046) Date: July 7, 2025 The following communication was posted on X by CoreWeave, Inc. on July 7, 2025 in connection with CoreWeave's proposed acquisi |
|
| July 7, 2025 |
Filed by Core Scientific, Inc. 425 Filed by Core Scientific, Inc. (Commission File No.: 001-40046) Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Core Scientific, Inc. (Commission File No.: 001-40046) The following set of Frequently Asked Questions (“FAQs”) were distributed by Core Scientific, Inc. to its employees on July |
|
| July 7, 2025 |
425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| July 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| July 7, 2025 |
EX-99.1 Exhibit 99.1 CoreWeave to Acquire Core Scientific Verticalizes Data Center Ownership to Help Future-Proof Revenue Growth and Enhance Core Profitability Livingston, NJ and Austin, TX – July 7, 2025 – CoreWeave (NASDAQ: CRWV), the AI Hyperscaler™, and Core Scientific (NASDAQ: CORZ), a leading data center infrastructure provider, today announced that they have signed a definitive agreement un |
|
| July 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| July 7, 2025 |
Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among COREWEAVE, INC, MIAMI MERGER SUB I, INC., and CORE SCIENTIFIC, INC. dated as of July 7, 2025 TABLE OF CONTENTS Page No. ARTICLE I DEFINITIONS 2 Section 1.01. Certain Definitions 2 Section 1.02. Other Defined Terms 18 Section 1.03. Other Definitional Provisions 20 ARTICLE II THE MERGER 21 Section 2.01. The Merger 21 Section 2.0 |
|
| July 7, 2025 |
Filed by Core Scientific, Inc. (Commission File No.: 001-40046) Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Core Scientific, Inc. (Commission File No.: 001-40046) The following communications were made by Core Scientific, Inc. in connection with the proposed acquisition of Core Scientific, |
|
| May 27, 2025 |
Fourth Amended and Restated Certificate of Incorporation of Core Scientific, Inc. Exhibit 3.1 FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CORE SCIENTIFIC, INC. The undersigned, being the Secretary of Core Scientific, Inc. (originally incorporated under the name Power & Digital Infrastructure Acquisition Corp.) (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of the Delaware (as it now exist |
|
| May 27, 2025 |
Third Amended and Restated Bylaws of Core Scientific, Inc. Exhibit 3.2 THIRD AMENDED AND RESTATED BYLAWS OF CORE SCIENTIFIC, INC. (A DELAWARE CORPORATION) ARTICLE I OFFICES Section 1. Registered Office. The registered office of the corporation in the State of Delaware shall be as set forth in the Fourth Amended and Restated Certificate of Incorporation of the corporation, as the same may be amended or restated from time to time (the “Certificate of Incorp |
|
| May 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| May 23, 2025 |
Calculation of Filing Fee Tables S-8 Core Scientific, Inc./tx Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, $0.00001 par value per share Other 48,000,000 $ 10.61 $ 509,280,000.00 0.0001531 $ 77,970.77 T |
|
| May 23, 2025 |
As filed with the Securities and Exchange Commission on May 23, 2025 As filed with the Securities and Exchange Commission on May 23, 2025 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CORE SCIENTIFIC, INC. (Exact name of registrant as specified in its charter) Delaware 86-1243837 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Ide |
|
| May 16, 2025 |
Core Scientific Announces Departure of Board Member Todd Becker Exhibit 99.1 Core Scientific Announces Departure of Board Member Todd Becker AUSTIN, Texas, May 13, 2025 - Core Scientific, Inc. (NASDAQ: CORZ), a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced that Todd Becker will be stepping down from its Board of Directors, effective immediately. Mr. Becker joined the Board in January 2024 and ha |
|
| May 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| May 16, 2025 |
Exhibit 99.2 May 16, 2025 Core Scientific Appoints Elizabeth Crain to Board of Directors Jordan Levy Elected Chairman of the Board AUSTIN, Texas, May 16, 2025 - Core Scientific, Inc. (NASDAQ: CORZ), a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced the appointment of Elizabeth Crain to its Board of Directors, effective immediately. Ms |
|
| May 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| May 13, 2025 |
Core Scientific, Inc. Amended and Restated 2024 Stock Incentive Plan, dated May 12, 2025. CORE SCIENTIFIC, INC. AMENDED AND RESTATED 2024 STOCK INCENTIVE PLAN I. INTRODUCTION 1.1Purposes. The purposes of the Core Scientific, Inc. Amended and Restated 2024 Stock Incentive Plan (this “Plan”) are (i) to align the interests of the Company’s stockholders and the recipients of awards under this Plan by increasing the proprietary interest of such recipients in the Company’s growth and success |
|
| May 7, 2025 |
Core Scientific Announces Fiscal First Quarter 2025 Results First Quarter 2025 Highlights Exhibit 99.1 Core Scientific Announces Fiscal First Quarter 2025 Results First Quarter 2025 Highlights •On track to deliver 250MW of billable capacity to CoreWeave by the end of this year and anticipate entering 2026 with annualized colocation revenue of approximately $360 million. •First tranche of 8MW of billable capacity at Denton to be delivered to CoreWeave by the end of this month and an add |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00 |
|
| May 7, 2025 |
First Quarter 2025 Earnings Presentation Adam Sullivan, CEO Jim Nygaard, CFO Matt Brown, COO May 7, 2025 2 FORWARD-LOOKING STATEMENTS This presentation contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding projections, estimates and forecasts of revenue and |
|
| May 7, 2025 |
Restricted Stock Unit Award Agreement pursuant to Core Scientific, Inc. 2024 Stock Incentive Plan CORE SCIENTIFIC, INC. 2024 STOCK INCENTIVE PLAN Restricted Stock Unit Award Notice You have been awarded a restricted stock unit award with respect to shares of Common Stock of Core Scientific, Inc., a Delaware corporation (the “Company”), pursuant to the terms and conditions of the Core Scientific, Inc. 2024 Stock Incentive Plan (the “Plan”) and the Restricted Stock Unit Award Agreement (together |
|
| May 7, 2025 |
and Core Scientific, Inc., dated EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) dated as of February 26, 2025 (the “Effective Date”) is made by and between Core Scientific, Inc. |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| May 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 8, 2025 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 32 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| April 7, 2025 |
press release corescientific.com Core Scientific Announces March 2025 Production and Operations Updates Earned 247 Self-Mined Bitcoin for a Total of 718 Bitcoin Year-to-Date and Our Customers Earned an Estimated 17 Bitcoin at Our Data Centers in March AUSTIN, Texas, April 7, 2025 – Core Scientific, Inc. (Nasdaq: CORZ) ("Core Scientific" or “the Company”), a leader in digital infrastructure for hig |
|
| April 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fil |
|
| March 28, 2025 |
Table of Contents SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 13, 2025 |
to the Securities and Exchange Commission, dated March 13, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Core Scientific, Inc. under Item 4.01 of its Form 8-K dated March 12, 2025. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Core Scientific, Inc. contained therein. Very |
|
| March 13, 2025 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 31 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| March 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 12, 2025 |
Table of Contents SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 7, 2025 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 29 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| March 7, 2025 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 30 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| March 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fil |
|
| March 6, 2025 |
March 5, 2025 Core Scientific Announces February 2025 Production and Operations Updates Earned 215 Self-Mined Bitcoin for a Total of 471 Bitcoin Year-to-Date and Our Customers Earned an Estimated 16 Bitcoin at Our Data Centers in February AUSTIN, Texas-(BUSINESS WIRE)- Core Scientific, Inc. |
|
| March 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fil |
|
| March 4, 2025 |
Exhibit 99.1 Core Scientific Announces Planned CFO Transition Company Welcomes Veteran Finance Executive, Jim Nygaard, as New CFO Effective March 17 March 3, 2025 AUSTIN, Texas-(BUSINESS WIRE)- Core Scientific, Inc. (NASDAQ: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-performance computing (HPC), today announced that Jim Nygaard will succeed Denise Sterl |
|
| February 27, 2025 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 27 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| February 27, 2025 |
exhibit19insidertradingp 106 E. 6th Street, Suite 900-145, Austin TX 78701 www.corescientific.com | 425-998-5300 Insider Trading Policy I. Policy Principles • Employees, officers, directors, and designated consultants (each a “Covered Person,” and collectively, “Covered Persons”) of Core Scientific, Inc. and its subsidiaries (together, the “Company”) are responsible for understanding the obligatio |
|
| February 27, 2025 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 28 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| February 27, 2025 |
press release corescientific.com Core Scientific and CoreWeave Announce $1.2 Billion Expansion at Denton, TX Site Expands Total Contracted HPC Infrastructure by CoreWeave to Approximately 590 Megawatts of Critical IT Load at Six Core Scientific Sites New Agreement Boosts Total Contracted Revenue to $10.2 Billion over 12-year Contract Terms AUSTIN, Texas – February 26, 2025 – Core Scientific, Inc. |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-400 |
|
| February 27, 2025 |
Exhibit 21.1 Subsidiaries of Core Scientific, Inc. Name of Subsidiary Jurisdiction of Incorporation American Property Acquisition, LLC Delaware American Property Acquisition I, LLC North Carolina American Property Acquisitions VII, LLC Georgia Core Scientific Mining (Oklahoma) LLC Delaware |
|
| February 26, 2025 |
Fourth Quarter Fiscal 2024 Earnings Presentation Adam Sullivan, CEO Denise Sterling, CFO February 26, 2025 2 FORWARD-LOOKING STATEMENTS This presentation contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding projections, estimates and forecasts of revenue a |
|
| February 26, 2025 |
press release Exhibit 99.1 corescientific.com Core Scientific Announces Fiscal Fourth Quarter and Full Fiscal Year 2024 Results Fourth Quarter 2024 Highlights •Incurred net loss of $265.5 million due primarily to a $224.7 million non-cash mark-to-market adjustment to warrants and other contingent value right liabilities required by the significant year-over-year increase in our share price •Report |
|
| February 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| February 13, 2025 |
Exhibit 99.1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common stock, par val |
|
| February 5, 2025 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 26 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| February 5, 2025 |
press release corescientific.com Core Scientific Announces January 2025 Production and Operations Updates Earned 256 Self-Mined Bitcoin; Our Customers Earned an Estimated 17 Bitcoin at Our Data Centers in January AUSTIN, Texas, January 5, 2025 – Core Scientific, Inc. (Nasdaq: CORZ) ("Core Scientific" or “the Company”), a leader in digital infrastructure for high-performance computing and bitcoin m |
|
| February 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| January 6, 2025 |
press release Exhibit 99.1 corescientific.com Core Scientific Announces December 2024 Production and Operations Updates Earned 291 Self-Mined Bitcoin for a Total of 6,595 Bitcoin Year-to-Date and 974 in the Fourth Quarter; Our Customers Earned an Estimated 18 Bitcoin at Our Data Centers in December AUSTIN, Texas, December 6, 2024 – Core Scientific, Inc. (Nasdaq: CORZ) ("Core Scientific" or “the Co |
|
| January 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2025 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission F |
|
| January 6, 2025 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 25 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| December 6, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 24 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| December 6, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 23 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| December 5, 2024 |
Exhibit 99.1 press release corescientific.com Core Scientific Announces November 2024 Production and Operations Updates Earned 314 Self-Mined Bitcoin for a Total of 6,304 Bitcoin Year-to-Date and Our Customers Earned an Estimated 29 Bitcoin at Our Data Centers in November AUSTIN, Texas, November 5, 2024 – Core Scientific, Inc. (Nasdaq: CORZ) ("Core Scientific" or “the Company”), a leader in digita |
|
| December 5, 2024 |
Core Scientific Prices Upsized $550 Million Convertible Senior Notes Offering Exhibit 99.2 Core Scientific Prices Upsized $550 Million Convertible Senior Notes Offering December 3, 2024 AUSTIN, Texas- Core Scientific, Inc. (NASDAQ: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for bitcoin mining and high-performance computing, today announced the pricing of its offering of $550 million aggregate principal amount of 0.00% convertible senior n |
|
| December 5, 2024 |
Exhibit 4.1 ═══════════════════════════════════════════════════════ ═══════════════════════════════════════════════════════ CORE SCIENTIFIC, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee ───────────────────── INDENTURE Dated as of December 5, 2024 ───────────────────── 0.00% Convertible Senior Notes due 2031 ═══════════════════════════════════════════════════════ ══════════════ |
|
| December 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| December 5, 2024 |
Core Scientific Announces Proposed Convertible Senior Notes Offering Exhibit 99.1 Core Scientific Announces Proposed Convertible Senior Notes Offering December 2, 2024 AUSTIN, Texas- Core Scientific, Inc. (NASDAQ: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for bitcoin mining and high-performance computing, today announced its intention to offer, subject to market and other conditions, $500 million aggregate principal amount of co |
|
| December 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| December 3, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 20 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| December 3, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 22 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| December 3, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock 424B3 1 a11624prospectussupplement.htm 424B3 Prospectus Supplement No. 21 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amende |
|
| December 2, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 19 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| November 25, 2024 |
press release Exhibit 99.1 corescientific.com Core Scientific Announces Approval of Lease Amendments with the City of Denton to Enable High-Performance Computing Expansion Company growth continues in support of high-performance compute customers Denton, TX, Nov. 20, 2024 – Core Scientific Inc. (Nasdaq: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-performa |
|
| November 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 |
|
| November 6, 2024 |
Core Scientific Announces Fiscal Third Quarter 2024 Results Fiscal Third Quarter 2024 Highlights press release Exhibit 99.1 corescientific.com Core Scientific Announces Fiscal Third Quarter 2024 Results Fiscal Third Quarter 2024 Highlights •Incurred net loss of $455.3 million due primarily to a net $408.5 million non-cash mark-to-market adjustment to our warrants and other contingent value right liabilities required as a result of significant quarter-over-quarter increase in the value of our |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| November 6, 2024 |
Third Quarter Fiscal 2024 Earnings Presentation Adam Sullivan, CEO Denise Sterling, CFO November 6, 2024 2 FORWARD-LOOKING STATEMENTS This presentation contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding projections, estimates and forecasts of revenue and |
|
| November 5, 2024 |
press release Exhibit 99.1 corescientific.com Core Scientific Announces October 2024 Production and Operations Updates Earned 369 Self-Mined Bitcoin for a Total of 5,990 Bitcoin Year-to-Date and Our Customers Earned an Estimated 52 Bitcoin at Our Data Centers in October AUSTIN, Texas, November 5, 2024 – Core Scientific, Inc. (Nasdaq: CORZ) ("Core Scientific" or “the Company”), a leader in digital |
|
| November 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| October 23, 2024 |
press release corescientific.com Core Scientific Announces Exercise of Final Contract Option by CoreWeave for Delivery of Approximately 120 MW of Additional Digital Infrastructure to Host High-Performance Computing Operations Expands Total Contracted HPC Infrastructure by CoreWeave to Approximately 500 Megawatts of Critical IT Load at Six Core Scientific Sites Increases Potential Cumulative Revenu |
|
| October 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| October 8, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 18 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| October 7, 2024 |
press release corescientific.com Core Scientific Announces September 2024 Production and Operations Updates Earned 345 Self-Mined Bitcoin in September for a Total of 5,621 Bitcoin Year-to-Date and 1,115 in the Third Quarter; Clients Earned an Estimated 66 Bitcoin at Our Data Centers in September AUSTIN, Texas, September 7, 2024 – Core Scientific, Inc. (Nasdaq: CORZ) ("Core Scientific" or “the Comp |
|
| October 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission F |
|
| September 9, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 17 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| September 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| September 6, 2024 |
Core Scientific Announces CFO Transition Plan Exhibit 99.1 press release corescientific.com Core Scientific Announces CFO Transition Plan AUSTIN, Texas – September 6, 2024 – Core Scientific, Inc. (NASDAQ: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for bitcoin mining and high-performance computing, today announced that Denise Sterling has decided to step down from her role as Executive Vice President and Chi |
|
| September 6, 2024 |
EX-10.1 2 exhibit101-transitionandse.htm EX-10.1 Exhibit 10.1 TRANSITION AND SEPARATION AGREEMENT This TRANSITION AND SEPARATION AGREEMENT (this “Agreement”) dated as of September 4, 2024 is made by and between Core Scientific, Inc. (the “Company”) and Denise Sterling (the “Executive”). WHEREAS, the Executive has been employed by the Company as Executive Vice President and Chief Financial Officer; |
|
| September 6, 2024 |
EX-10.2 3 exhibit102-formofrestricte.htm EX-10.2 Exhibit 10.2 CORE SCIENTIFIC, INC. 2024 STOCK INCENTIVE PLAN Restricted Stock Unit Award Notice Denise Sterling You have been awarded a restricted stock unit award with respect to shares of Common Stock of Core Scientific, Inc., a Delaware corporation (the “Company”), pursuant to the terms and conditions of the Core Scientific, Inc. 2024 Stock Incen |
|
| September 5, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 16 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| September 5, 2024 |
press release corescientific.com Core Scientific Announces August 2024 Production and Operations Updates Earned 358 Self-Mined Bitcoin for a Total of 5,275 Bitcoin Year-to-Date and Our Customers Earned an Estimated 90 Bitcoin at Our Data Centers in August AUSTIN, Texas, Sept. 5, 2024 – Core Scientific, Inc. (Nasdaq: CORZ) ("Core Scientific" or “the Company”), a leader in digital infrastructure for |
|
| September 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| August 19, 2024 |
CORZ / Core Scientific, Inc. / Beryl Capital Management LLC Passive Investment SC 13G 1 corescientific13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Core Scientific, Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 21874A106 (CUSIP Number) August 9, 2024 (Date of Event Which Requires Filing of this Statement) Check the appro |
|
| August 19, 2024 |
NOTICE OF FULL REDEMPTION CORE SCIENTIFIC, INC. 12.50% Secured Notes due 2028 (the “Notes”) CUSIP No. 21874A AA4 ISIN NO: US21874AAA43 NOTICE IS HEREBY GIVEN TO THE HOLDERS of the above-referenced Notes Pursuant to Section 3.09 of the Indenture, dated as of January 23, 2024 (the “Indenture”) by and among Core Scientific, Inc., as Issuer (the “Issuer”), the guarantors party thereto from time to tim |
|
| August 19, 2024 |
EXECUTION VERSION ═══════════════════════════════════════════════════════ ═══════════════════════════════════════════════════════ CORE SCIENTIFIC, INC. |
|
| August 19, 2024 |
Core Scientific Announces Proposed Convertible Senior Notes Offering Core Scientific Announces Proposed Convertible Senior Notes Offering August 13, 2024 AUSTIN, Texas- Core Scientific, Inc. |
|
| August 19, 2024 |
Core Scientific Prices Upsized $400 Million Convertible Senior Notes Offering Core Scientific Prices Upsized $400 Million Convertible Senior Notes Offering August 14, 2024 AUSTIN, Texas- Core Scientific, Inc. |
|
| August 19, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 15 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| August 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission F |
|
| August 7, 2024 |
Second Quarter Fiscal 2024 Earnings Presentation Adam Sullivan, CEO Denise Sterling, CFO August 7, 2024 2 FORWARD-LOOKING STATEMENTS This presentation contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding projections, estimates and forecasts of revenue and |
|
| August 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fi |
|
| August 7, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 14 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| August 7, 2024 |
Core Scientific Announces Fiscal Second Quarter 2024 Results Fiscal Second Quarter 2024 Highlights press release Exhibit 99.1 corescientific.com Core Scientific Announces Fiscal Second Quarter 2024 Results Fiscal Second Quarter 2024 Highlights •Incurred net loss of $804.9 million due primarily to a net $796.0 million non-cash mark-to-market adjustment to our warrants and other contingent value right liabilities required as a result of significant quarter-over-quarter increase in the value of ou |
|
| August 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 Core |
|
| August 6, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 13 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fi |
|
| August 6, 2024 |
Exhibit 99.1 press release corescientific.com Core Scientific Announces Exercise of Additional Contract Option by CoreWeave for Delivery of Approximately 112 MW of Additional Infrastructure to Host High-Performance Computing Operations Expands Total Contracted HPC Infrastructure by CoreWeave to 382 Megawatts at Five Core Scientific sites Increases Potential Cumulative Revenue to More than $6.7 Bil |
|
| August 5, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 12 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| August 5, 2024 |
press release corescientific.com Core Scientific Announces July 2024 Production and Operations Updates Earned 411 Self-Mined Bitcoin for a Total of 4,917 Bitcoin Year-to-Date and Our Customers Earned an Estimated 109 Bitcoin at Our Data Centers in July First Bitcoin Miner to Support Foundry Donate, a Program to Fund Bitcoin Network Core Developers AUSTIN, Texas, August 5, 2024 – Core Scientific, I |
|
| August 5, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fi |
|
| July 23, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 11 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| July 23, 2024 |
Exhibit 10.3 CORE SCIENTIFIC, INC. 2024 STOCK INCENTIVE PLAN Performance Share Unit Award Notice Recipient You have been awarded a performance share unit award with respect to shares of Common Stock of Core Scientific, Inc., a Delaware corporation (the “Company”), pursuant to the terms and conditions of the Core Scientific, Inc. 2024 Stock Incentive Plan (the “Plan”) and the Performance Share Unit |
|
| July 23, 2024 |
Exhibit 10.2 CORE SCIENTIFIC, INC. 2024 STOCK INCENTIVE PLAN Restricted Stock Unit Award Notice Recipient You have been awarded a restricted stock unit award with respect to shares of Common Stock of Core Scientific, Inc., a Delaware corporation (the “Company”), pursuant to the terms and conditions of the Core Scientific, Inc. 2024 Stock Incentive Plan (the “Plan”) and the Restricted Stock Unit Aw |
|
| July 23, 2024 |
Employment Agreement, by and between Todd M. DuChene and Core Scientific, Inc., dated July 19, 2024 Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) dated as of July 19, 2024 (the “Effective Date”) is made by and between Core Scientific, Inc. (the “Company”) and Todd DuChene (the “Executive”). WHEREAS, the Executive has been employed by the Company as Executive Vice President, Chief Legal and Administrative Officer, Chief Compliance Officer and Secretary; and WHEREA |
|
| July 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fil |
|
| July 12, 2024 |
Exhibit 99.1 press release corescientific.com Core Scientific Announces Tranche 2 Warrants Triggering Event Strong Share Price Performance Makes Tranche 2 Warrants Exercisable until January 23, 2029 AUSTIN, Texas – July 12, 2024 – Core Scientific, Inc. (NASDAQ: CORZ) (“Core Scientific” or the “Company”), one of the largest owners and operators of high-powered digital infrastructure for bitcoin min |
|
| July 12, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 10 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospec |
|
| July 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fil |
|
| July 8, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 9 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospect |
|
| July 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 8, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| July 8, 2024 |
press release corescientific.com Core Scientific Announces Mandatory Conversion of Outstanding Secured Convertible Notes Strong Business Momentum and Share Trading Performance Trigger Conversion of Outstanding Convertible Notes, Completing the Elimination of $260 Million of Debt from Balance Sheet AUSTIN, Texas – July 8, 2024 – Core Scientific, Inc. (NASDAQ: CORZ) (“Core Scientific” or the “Compan |
|
| July 5, 2024 |
press release corescientific.com Core Scientific Announces June 2024 Production and Operations Updates Secured High-Performance Computing (HPC) Hosting Contracts with CoreWeave for 270 MW of Infrastructure, Representing Total Revenue Opportunity of More than $4.7 Billion over 12-Year Terms Earned 430 Self-Mined Bitcoin for a Total of 4,506 Bitcoin Year-to-Date and 1,680 in the Second Quarter; Clie |
|
| July 5, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 8 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospect |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 5, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| June 26, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 6 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospect |
|
| June 26, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 3 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospect |
|
| June 26, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 5 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospect |
|
| June 26, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 4 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospect |
|
| June 26, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock 424B3 1 prospectissupplement-64248.htm 424B3 Prospectus Supplement No. 2 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended |
|
| June 26, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 7 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospect |
|
| June 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fil |
|
| June 25, 2024 |
Exhibit 99.1 press release corescientific.com Core Scientific Announces New Contract with CoreWeave for Delivery of Approximately 70 MW of Additional Infrastructure to Host High-Performance Computing Operations Marks Another Meaningful Step in Execution of Portfolio Diversification Strategy Increases Total Owned and Contracted Infrastructure Allocated for HPC Hosting to Approximately 270 MW AUSTIN |
|
| June 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fil |
|
| June 17, 2024 |
Exhibit 10.3 CORE SCIENTIFIC, INC. 2024 STOCK INCENTIVE PLAN Performance Share Unit Award Notice Recipient You have been awarded a performance share unit award with respect to shares of Common Stock of Core Scientific, Inc., a Delaware corporation (the “Company”), pursuant to the terms and conditions of the Core Scientific, Inc. 2024 Stock Incentive Plan (the “Plan”) and the Performance Share Unit |
|
| June 17, 2024 |
Exhibit 10.2 CORE SCIENTIFIC, INC. 2024 STOCK INCENTIVE PLAN Restricted Stock Unit Award Notice Recipient You have been awarded a restricted stock unit award with respect to shares of Common Stock of Core Scientific, Inc., a Delaware corporation (the “Company”), pursuant to the terms and conditions of the Core Scientific, Inc. 2024 Stock Incentive Plan (the “Plan”) and the Restricted Stock Unit Aw |
|
| June 17, 2024 |
Employment Agreement, by and between Adam Sullivan and Core Scientific, Inc., dated June 14, 2024 ex101corz-ceoemploymenta Execution Version EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the “Agreement”) dated as of June , 2024 (the “Effective Date”) is made by and between Core Scientific, Inc. |
|
| June 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fil |
|
| June 12, 2024 |
corescientificinvestorda INVESTOR AND ANALYST DAY June 12, 2024 Denton, TX 2 FORWARD-LOOKING STATEMENTS This presentation contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding projections, estimates and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the Company’s ability to scale and grow its business, source clean and renewable energy, the advantages and expected growth of the Company and the Company’s ability to source and retain talent. |
|
| June 6, 2024 |
Exhibit 99.1 press release corescientific.com Core Scientific Rejects Unsolicited Proposal from CoreWeave Proposal Significantly Undervalues the Company and Is Not in the Best Interests of Core Scientific and its Shareholders Core Scientific Remains Focused on Executing Previously Announced Series of 12-Year Contracts with CoreWeave, which Are Expected to Generate Over $3.5 Billion in Cumulative R |
|
| June 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| June 5, 2024 |
Core Scientific Announces May 2024 Production and Operations Updates Exhibit 99.1 press release corescientific.com Core Scientific Announces May 2024 Production and Operations Updates •Earned 447 self-mined bitcoin for a total of 4,076 bitcoin year-to-date, and our customers earned an estimated 128 bitcoin at our data centers in May •Operated approximately 219,000 owned and hosted bitcoin miners for a total energized hash rate of 26.1 exahash as of May 31, 2024 AUS |
|
| June 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| June 4, 2024 |
Exhibit 99.1 press release corescientific.com Core Scientific to Provide Approximately 200 MW of Infrastructure to Host CoreWeave’s High-Performance Computing Services, Capturing Significant AI Compute Opportunity Transforms and Expands Core Scientific’s Hosting Business and Earnings Power While Maintaining Bitcoin Mining Capacity and Growth Potential Long-Term Hosting Agreements Expected to Gener |
|
| June 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| June 4, 2024 |
finalcorzhpcreleaseslide 1 JUNE 3, 2024 Core Scientific Announces Strategic Expansion of HPC Business with Multi-Year CoreWeave Hosting Agreements JUNE 3, 2024 2 JUNE 3, 2024 Forward-looking statements This presentation of Core Scientific, Inc. |
|
| May 21, 2024 |
Exhibit 107 Calculation of Filing Fee Table FORM S-8 (Form Type) Core Scientific, Inc. |
|
| May 21, 2024 |
As filed with the Securities and Exchange Commission on May 21, 2024 S-8 As filed with the Securities and Exchange Commission on May 21, 2024 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CORE SCIENTIFIC, INC. (Exact name of registrant as specified in its charter) Delaware 86-1243837 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer I |
|
| May 9, 2024 |
Core Scientific, Inc. 10,795,751 Shares of Common Stock Prospectus Supplement No. 1 (to Prospectus dated May 3, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 Core Scientific, Inc. 10,795,751 Shares of Common Stock This prospectus supplement updates and supplements the prospectus dated May 3, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-278676). This prospect |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 Cor |
|
| May 8, 2024 |
1 MAY 8, 2024 First Quarter Fiscal 2024 Earnings Presentation MAY 8, 2024 Adam Sullivan, CEO Denise Sterling, CFO 2 MAY 8, 2024 This presentation contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding projections, estimates and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the Company’s ability to scale and grow its business, source clean and renewable energy, the advantages and expected growth of the Company and the Company’s ability to source and retain talent. |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| May 8, 2024 |
Core Scientific Announces Fiscal First Quarter 2024 Results Fiscal First Quarter 2024 Highlights press release Exhibit 99.1 corescientific.com Core Scientific Announces Fiscal First Quarter 2024 Results Fiscal First Quarter 2024 Highlights •Generated net income of $210.7 million, including a gain on extinguishment of prior obligations of $143.8 million •Produced adjusted EBITDA of $88.0 million •Strengthened the balance sheet, ending the quarter with $98.1 million in cash and cash equivalents |
|
| May 6, 2024 |
10,795,751 Shares of Common Stock Filed Pursuant to Rule 424(b)(3) Registration No. 333-278676 PROSPECTUS 10,795,751 Shares of Common Stock This prospectus relates to the resale of (i) up to 10,735,143 shares (the “Bitmain Shares”) of our common stock, $0.00001 per share (the “Common Stock”), by Tospring Technology Limited (“Bitmain”) and (ii) up to 60,608 shares of our Common Stock (the “OGE Settlement Shares” and, together with |
|
| May 6, 2024 |
Core Scientific Announces April 2024 Production and Operations Updates press release corescientific.com Core Scientific Announces April 2024 Production and Operations Updates •Earned 803 self-mined bitcoin for a total of 3,628 bitcoin year-to-date, and our customers earned an estimated 265 bitcoin at our data centers in April •Completed deployment of 2.5 EH/s of S21 miners from previously announced order •Operated approximately 224,000 owned and hosted bitcoin miners |
|
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission File |
|
| May 2, 2024 |
Core Scientific, Inc. 2024 Stock Incentive Plan, dated as of April 26, 2024. Exhibit 10.1 CORE SCIENTIFIC, INC. 2024 STOCK INCENTIVE PLAN I. INTRODUCTION I.1Purposes. The purposes of the Core Scientific, Inc. 2024 Stock Incentive Plan (this “Plan”) are (i) to align the interests of the Company’s stockholders and the recipients of awards under this Plan by increasing the proprietary interest of such recipients in the Company’s growth and success, (ii) to advance the interes |
|
| May 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 30, 2024 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) Core Scientific, Inc. |
|
| April 30, 2024 |
As filed with the U.S. Securities and Exchange Commission on April 29, 2024. As filed with the U.S. Securities and Exchange Commission on April 29, 2024. Registration No. 333-278676 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CORE SCIENTIFIC, INC. (Exact name of registrant as specified in its charter) Delaware 7370 86-1243837 (State or other jurisdiction of incor |
|
| April 29, 2024 |
Core Scientific, Inc. 838 Walker Road, Suite 21-2105 Dover, DE 19904 April 29, 2024 Core Scientific, Inc. 838 Walker Road, Suite 21-2105 Dover, DE 19904 April 29, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Crypto Assets 100 F Street, N.E. Washington, D.C. 20549 Attention: Lulu Cheng Re: Core Scientific, Inc. Registration Statement on Form S-1 (File No. 333-278676) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities |
|
| April 15, 2024 |
As filed with the U.S. Securities and Exchange Commission on April 12, 2024. As filed with the U.S. Securities and Exchange Commission on April 12, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CORE SCIENTIFIC, INC. (Exact name of registrant as specified in its charter) Delaware 7370 86-1243837 (State or other jurisdiction of incorporation or organization) |
|
| April 15, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 15, 2024 |
Core Scientific Files Registration Statement for Shares Held by Existing Shareholders Exhibit 99.1 press release Core Scientific Files Registration Statement for Shares Held by Existing Shareholders •The 10.8 million shares associated with registration statement are included in Core Scientific's 177.6 million total current share count as of April 11, 2024 AUSTIN, Texas, Apr. 15, 2024 – Core Scientific, Inc. (Nasdaq: CORZ) ("Core Scientific" or “the Company”), a leader in bitcoin mi |
|
| April 15, 2024 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) Core Scientific, Inc. |
|
| April 15, 2024 |
Exhibit 21.1 Subsidiaries of Core Scientific, Inc. Name of Subsidiary Jurisdiction of Incorporation American Property Acquisition, LLC Delaware American Property Acquisition I, LLC North Carolina American Property Acquisitions VII, LLC Georgia Core Scientific Mining (Oklahoma) LLC Delaware |
|
| April 5, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 5, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fil |
|
| April 5, 2024 |
Core Scientific Announces March 2024 Production and Operations Updates press release corescientific.com Core Scientific Announces March 2024 Production and Operations Updates •Earned 906 self-mined bitcoin and our customers earned an estimated 309 bitcoin at our data centers in March for a first quarter total of 2,825 self-mined bitcoin and an estimated 970 customer-earned bitcoin •Deployed first shipment of approximately 2,500 S21 miners from previously announced or |
|
| April 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fil |
|
| March 13, 2024 |
CORE SCIENTIFIC, INC. POLICY ON RECOUPMENT OF INCENTIVE COMPENSATION Introduction The Board of Directors (the “Board”) of Core Scientific, Inc. (the “Company”) has adopted this Policy on Recoupment of Incentive Compensation (this “Policy”), which provides for the recoupment of compensation in certain circumstances in the event of a restatement of financial results by the Company. This Policy shall |
|
| March 13, 2024 |
Letter Agreement by and between Adam Sullivan and Core Scientific Holding Co., dated April 5, 2023. exhibit1097-letterofagre |
|
| March 13, 2024 |
EX-21.1 9 d285128dex211.htm EX-21.1 Exhibit 21.1 Subsidiaries of Core Scientific, Inc. Name of Subsidiary Jurisdiction of Incorporation American Property Acquisition, LLC Delaware American Property Acquisition I, LLC North Carolina American Property Acquisitions VII, LLC Georgia Core Scientific Mining (Oklahoma) LLC Delaware |
|
| March 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 Core Scientific |
|
| March 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 12, 2024 |
press release Exhibit 99.1 corescientific.com Core Scientific Announces Fiscal Fourth Quarter and Full Fiscal Year 2023 Results Fiscal Year 2023 Highlights •A total of 19,274 bitcoin earned in our data centers; 13,762 bitcoin by self-mining for our account, more than any other publicly listed miner in North America, and an estimated 5,512 for our hosting clients’ accounts •Operated total hash rate |
|
| March 12, 2024 |
finalcorzfy2023earningsp 1 MAR 12, 2024 Fiscal Fourth Quarter and Full Year 2023 Earnings Presentation MARCH 12, 2024 Adam Sullivan, CEO Denise Sterling, CFO 2 MAR 12, 2024 This presentation contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding projections, estimates and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the Company’s ability to scale and grow its business, source clean and renewable energy, the advantages and expected growth of the Company and the Company’s ability to source and retain talent. |
|
| March 6, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fil |
|
| March 6, 2024 |
press release Core Scientific to Provide CoreWeave up to 16 MW of Data Center Infrastructure to Support AI and HPC Workloads in Long Term Hosting Contract with Potential Revenue of More than $100 Million •Strategic extension of data center hosting business levers Core Scientific’s expertise in high value compute to broaden revenue model to customers engaged in rapidly growing High-Performance Computing (“HPC”) •Core Scientific leases Austin, TX data center formerly housing Hewlett Packard; provides basis for potential growth opportunities with expanded infrastructure •The Company expects this contract to be accretive to 2024 earnings AUSTIN, Texas, March 6, 2024 – Core Scientific, Inc. |
|
| March 5, 2024 |
Core Scientific Announces February 2024 Production and Operations Updates Core Scientific Announces February 2024 Production and Operations Updates •Operated approximately 222,000 owned and hosted bitcoin miners •Earned 893 self-mined bitcoin and our customers earned an estimated 307 bitcoin in our data centers in February •Increased self-mining hash rate by redeploying previous generation miners •Completed all payments due in 2024 for previously announced miner orders AUSTIN, Texas, Mar. |
|
| March 5, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 21, 2024 |
CORZ / Core Scientific, Inc. / Feinstein Darin - SC 13D/A Activist Investment SC 13D/A 1 d791854dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Core Scientific, Inc. (Name of Issuer) Common Stock, $0.00001 par value (Title of Class of Securities) 21874A106 (CUSIP Number) Darin Feinstein 3753 Howard Hughes Parkway Suite 200 Las Vegas, NV 89069 (702) 710 6390 |
|
| February 20, 2024 |
CORZ / Core Scientific, Inc. / LEVITT MICHAEL J - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. |
|
| February 20, 2024 |
CORZ / Core Scientific, Inc. / Minnis Matt - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. |
|
| February 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| February 5, 2024 |
Core Scientific Announces January 2024 Production and Operations Updates Exhibit 99.1 Core Scientific Announces January 2024 Production and Operations Updates a.Operated approximately 218,000 owned and hosted bitcoin miners b.Produced 1,027 self-mined bitcoin and an estimated 354 bitcoin from hosted miners in January c.Expanded self-mining energized hash rate by 1.7 EH/s with new miner deployments d.Improved self-mining fleet energy efficiency by five percent, to 26.44 |
|
| February 2, 2024 |
EX-99.1 2 d653792dex991.htm EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with |
|
| February 2, 2024 |
US21873J1088 / Core Scientific, Inc. / Tospring Technology Ltd - SC 13G Passive Investment SC 13G 1 d653792dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Core Scientific, Inc. (Name of Issuer) Common Stock, par value of $0.00001 per share (Title of Class of Securities) 21873J108 (CUSIP Number) January 23, 2024 (Date of Event Which Requires Filing of this Statement) Check |
|
| February 1, 2024 |
EX-99.9 Exhibit 99.9 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF TEXAS HOUSTON In Re. RADAR LLC § Case No. 22-90348 § § Lead Case No. 22-90341 Debtor(s) § ☒ Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 12/31/2023 Petition Date: 12/21/2022 Months Pending: 12 Industry Classification: 3 3 4 1 Reporting Method: Accrual Basis Cash Basis Debtor’s Ful |
|
| February 1, 2024 |
EX-99.5 Exhibit 99.5 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF TEXAS HOUSTON In Re. Radar Relay, Inc. § Case No. 22-90344 § § Lead Case No. 22-90341 Debtor(s) § ☒ Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 12/31/2023 Petition Date: 12/21/2022 Months Pending: 12 Industry Classification: 3 3 4 1 Reporting Method: Accrual Basi |
|
| February 1, 2024 |
EX-99.8 Exhibit 99.8 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF TEXAS HOUSTON In Re. Starboard Capital LLC § Case No. 22-90347 § § Lead Case No. 22-90341 Debtor(s) § ☒ Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 12/31/2023 Petition Date: 12/21/2022 Months Pending: 12 Industry Classification: 3 3 4 1 Reporting Method: Accrual Basis Cas |
|
| February 1, 2024 |
EX-99.11 Exhibit 99.11 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF TEXAS HOUSTON In Re. American Property Acquisitions VII, LLC § Case No. 22-90350 § § Lead Case No. 22-90341 Debtor(s) § ☒ Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 12/31/2023 Petition Date: 12/21/2022 Months Pending: 12 Industry Classification: 3 3 4 1 Reporting Method: Accr |
|
| February 1, 2024 |
EX-99.10 Exhibit 99.10 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF TEXAS HOUSTON In Re. American Property Acquisitions I, LLC § Case No. 22-90349 § § Lead Case No. 22-90341 Debtor(s) § ☒ Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 12/31/2023 Petition Date: 12/21/2022 Months Pending: 12 Industry Classification: 3 3 4 1 Reporting Method: Accrual B |
|
| February 1, 2024 |
EX-99.1 Exhibit 99.1 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF TEXAS HOUSTON In Re. Core Scientific, Inc. § Case No. 22-90341 § § Lead Case No. 22-90341 Debtor(s) § ☒ Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 12/31/2023 Petition Date: 12/21/2022 Months Pending: 12 Industry Classification: 3 3 4 1 Reporting Meth |
|
| February 1, 2024 |
EX-99.6 Exhibit 99.6 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF TEXAS HOUSTON In Re. Core Scientific Specialty Mining (Oklahoma) LLC § Case No. 22-90345 § Lead Case No. 22-90341 § Debtor(s) § ☒ Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 12/31/2023 Petition Date: 12/21/2022 Months Pending: 12 Industry Classification: 3 3 |
|
| February 1, 2024 |
EX-99.1 2 tm244829d1ex-1.htm EXHIBIT 1 Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the new common stock, $0.00001 par value per share, of Core Scientific, Inc., and furt |
|
| February 1, 2024 |
EX-99.4 Exhibit 99.4 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF TEXAS HOUSTON In Re. Core Scientific Acquired Mining LLC § Case No. 22-90342 § § Lead Case No. 22-90341 Debtor(s) § ☒ Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 12/31/2023 Petition Date: 12/21/2022 Months Pending: 12 Industry Classification: 3 3 4 1 Repo |
|
| February 1, 2024 |
EX-99.2 Exhibit 99.2 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF TEXAS HOUSTON In Re. Core Scientific Mining LLC § Case No. 22-90340 § Lead Case No. 22-90341 § Debtor(s) § ☒ Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 12/31/2023 Petition Date: 12/21/2022 Months Pending: 12 Industry Classification: 3 3 4 1 Reporting Meth |
|
| February 1, 2024 |
CRZWQ / Core Scientific, Inc. - Equity Warrant / Ibex Investors LLC - SC 13G Passive Investment SC 13G 1 tm244829d1sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Core Scientific, Inc. (Name of Issuer) Common Stock, $0.00001 par value per share (Title of Class of Securities) 21874A106 (CUSIP Number) January 23, 2024 (Date of Event Which Requires Filing of this Statement) Check th |
|
| February 1, 2024 |
EX-99.3 Exhibit 99.3 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF TEXAS HOUSTON In Re. Core Scientific Operating Company § Case No. 22-90343 § § Lead Case No. 22-90341 Debtor(s) § ☒ Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 12/31/2023 Petition Date: 12/21/2022 Months Pending: 12 Industry Classification: 3 3 4 1 Reporting Method: Accrual Bas |
|
| February 1, 2024 |
EX-99.7 Exhibit 99.7 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF TEXAS HOUSTON In Re. American Property Acquisition, LLC § Case No. 22-90346 § § Lead Case No. 22-90341 Debtor(s) § ☒ Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 12/31/2023 Petition Date: 12/21/2022 Months Pending: 12 Industry Classification: 3 3 4 1 Reporting Method: Accru |
|
| February 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| January 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorpo |
|
| January 25, 2024 |
EX-10.2 Exhibit 10.2 AMENDMENT TO ASSET PURCHASE AGREEMENT dated as of November 6, 2023 BY AND BETWEEN: BITMAIN TECHNOLOGIES DELAWARE LIMITED (as Vendor) - and - CORE SCIENTIFIC, INC. (as Purchaser) AMENDMENT TO ASSET PURCHASE AGREEMENT This AMENDMENT TO ASSET PURCHASE AGREEMENT (this “Amendment Agreement”), is made as of November 6, 2023 (the “Execution Date”), by and between Bitmain Technologies |
|
| January 25, 2024 |
EX-3.2 Exhibit 3.2 SECOND AMENDED AND RESTATED BYLAWS OF CORE SCIENTIFIC, INC. (A DELAWARE CORPORATION) ARTICLE I OFFICES Section 1. Registered Office. The registered office of the corporation in the State of Delaware shall be as set forth in the Third Amended and Restated Certificate of Incorporation of the corporation, as the same may be amended or restated from time to time (the “Certificate of |
|
| January 25, 2024 |
EX-10.4 Exhibit 10.4 Execution Version (Election 2) EQUIPMENT LOAN AND SECURITY AGREEMENT THIS EQUIPMENT LOAN AND SECURITY AGREEMENT (this “Agreement”) is dated as of January 23, 2024 (the “Closing Date”), by and between BlockFi Lending LLC (“Lender”) and Core Scientific, Inc., a Delaware corporation (“Borrower”). Capitalized terms used herein without definition shall have the meanings assigned to |
|
| January 25, 2024 |
EX-10.5 Exhibit 10.5 Execution Version (Election 2) EQUIPMENT LOAN AND SECURITY AGREEMENT THIS EQUIPMENT LOAN AND SECURITY AGREEMENT (this “Agreement”) is dated as of January 23, 2024 (the “Closing Date”), by and between Stonebriar Commercial Finance LLC (“Lender”) and Core Scientific, Inc., a Delaware corporation (“Borrower”). Capitalized terms used herein without definition shall have the meanin |
|
| January 25, 2024 |
US21873J1088 / Core Scientific, Inc. / BlackRock Inc. - SC 13D/A Activist Investment SC 13D/A 1 d545166dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Core Scientific, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 21873J108 (CUSIP Number) David Maryles Managing Director, Legal and Compliance BlackRock, Inc. 50 Hudson Yards New York, NY 10001 (2 |
|
| January 25, 2024 |
EX-10.6 Exhibit 10.6 Execution Version CONTINGENT VALUE RIGHTS AGREEMENT This CONTINGENT VALUE RIGHTS AGREEMENT (including the definitions set forth on Annex A and the provisions set forth on Annex B hereto, this “Agreement”), dated as of January 23, 2024, is by and between Core Scientific, Inc., a Delaware corporation (the “Company”) and Computershare Inc., a Delaware corporation (“Computershare” |
|
| January 25, 2024 |
EX-4.1 Exhibit 4.1 Execution Version CORE SCIENTIFIC, INC. AS ISSUER, THE GUARANTORS NAMED HEREIN AND WILMINGTON TRUST, NATIONAL ASSOCIATION, AS TRUSTEE AND COLLATERAL AGENT INDENTURE Dated as of January 23, 2024 10.00%/12.00% CASH/CASH-AND-PAYMENT IN STOCK CONVERTIBLE SECURED NOTES DUE 2029 CROSS-REFERENCE TABLE Reconciliation and tie showing the location in this Indenture of the provisions inser |
|
| January 25, 2024 |
EX-3.1 Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CORE SCIENTIFIC, INC. The undersigned, being the Secretary of Core Scientific, Inc. (originally incorporated under the name Power & Digital Infrastructure Acquisition Corp.) (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of the Delaware (as it now |
|
| January 25, 2024 |
EX-4.3 Exhibit 4.3 Execution Version WARRANT AGREEMENT BETWEEN CORE SCIENTIFIC, INC. AND COMPUTERSHARE TRUST COMPANY, N.A. AND COMPUTERSHARE INC., AS WARRANT AGENT JANUARY 23, 2024 TABLE OF CONTENTS Page SECTION 1. Appointment of Warrant Agent 2 SECTION 2. Issuances; Exercise Price 2 SECTION 3. Form of Warrants 2 SECTION 4. Execution of Global Warrant Certificates 3 SECTION 5. Registration and Cou |
|
| January 25, 2024 |
EX-10.3 Exhibit 10.3 EXECUTION VERSION CREDIT AND GUARANTY AGREEMENT Dated as of January 23, 2024, among CORE SCIENTIFIC, INC., as Borrower, CERTAIN SUBSIDIARIES OF CORE SCIENTIFIC, INC., as a Guarantor, THE LENDERS PARTY HERETO, and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Administrative Agent and Collateral Agent TABLE OF CONTENTS Page SECTION 1. DEFINITIONS; RULES OF CONSTRUCTION 2 1.1. Defin |
|
| January 25, 2024 |
EX-99.2 Exhibit 99.2 Core Scientific, Inc. Emergence Update* January 22, 2024 * This is only a summary. All shareholders and creditors should read the Plan and Disclosure Statement for details. 1 Legal Disclaimer This document is solely for informational purposes. You should not rely upon it or use it to form the definitive basis for any decision or action whatsoever, with respect to any proposed |
|
| January 25, 2024 |
EX-99.3 Exhibit 99.3 press release corescientific.com Core Scientific, Inc. Emerges from Chapter 11 with Strengthened Balance Sheet and Enhanced Competitive Position The Company maintains its position as one of the largest bitcoin miners in North America; Announces new Board of Directors AUSTIN, Texas, Jan. 23, 2024 – Core Scientific, Inc. (“Core Scientific” or the “Company”), a leader in bitcoin |
|
| January 25, 2024 |
EX-10.1 Exhibit 10.1 FOR EXECUTION ASSET PURCHASE AGREEMENT dated as of September 5, 2023 BY AND BETWEEN: BITMAIN TECHNOLOGIES DELAWARE LIMITED (as Vendor) - and - CORE SCIENTIFIC, INC. (as Purchaser) ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT (this “Agreement”), is made as of September 5, 2023 (the “Execution Date”), by and between Bitmain Technologies Delaware Limited, a corporation |
|
| January 25, 2024 |
Exhibit 4.2 Execution Version CORE SCIENTIFIC, INC. AS ISSUER, THE GUARANTORS NAMED HEREIN AND WILMINGTON TRUST, NATIONAL ASSOCIATION, AS TRUSTEE AND COLLATERAL AGENT INDENTURE Dated as of January 23, 2024 12.50% SECURED NOTES DUE 2028 CROSS-REFERENCE TABLE Reconciliation and tie showing the location in this Indenture of the provisions inserted pursuant to Sections 310 to 318(a), inclusive, of the |
|
| January 23, 2024 |
Third Amended and Restated Certificate of Incorporation of Core Scientific, Inc. EX-3.1 Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CORE SCIENTIFIC, INC. The undersigned, being the Secretary of Core Scientific, Inc. (originally incorporated under the name Power & Digital Infrastructure Acquisition Corp.) (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of the Delaware (as it now |
|
| January 23, 2024 |
EX-99.2 Exhibit 99.2 Core Scientific, Inc. Emergence Update* January 22, 2024 * This is only a summary. All shareholders and creditors should read the Plan and Disclosure Statement for details. 1 Legal Disclaimer This document is solely for informational purposes. You should not rely upon it or use it to form the definitive basis for any decision or action whatsoever, with respect to any proposed |
|
| January 23, 2024 |
Asset Purchase Agreement, dated as of September 5, 2023, by and between Bitmain and the Company. * EX-10.1 Exhibit 10.1 FOR EXECUTION ASSET PURCHASE AGREEMENT dated as of September 5, 2023 BY AND BETWEEN: BITMAIN TECHNOLOGIES DELAWARE LIMITED (as Vendor) - and - CORE SCIENTIFIC, INC. (as Purchaser) ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT (this “Agreement”), is made as of September 5, 2023 (the “Execution Date”), by and between Bitmain Technologies Delaware Limited, a corporation |
|
| January 23, 2024 |
EX-4.3 Exhibit 4.3 Execution Version WARRANT AGREEMENT BETWEEN CORE SCIENTIFIC, INC. AND COMPUTERSHARE TRUST COMPANY, N.A. AND COMPUTERSHARE INC., AS WARRANT AGENT JANUARY 23, 2024 TABLE OF CONTENTS Page SECTION 1. Appointment of Warrant Agent 2 SECTION 2. Issuances; Exercise Price 2 SECTION 3. Form of Warrants 2 SECTION 4. Execution of Global Warrant Certificates 3 SECTION 5. Registration and Cou |
|
| January 23, 2024 |
8-A12B/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A Amendment No. 1 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 86-1243837 (State or other jurisdiction of incorporation or organization) (I.R.S. Em |
|
| January 23, 2024 |
Second Amended and Restated Bylaws of Core Scientific, Inc. EX-3.2 Exhibit 3.2 SECOND AMENDED AND RESTATED BYLAWS OF CORE SCIENTIFIC, INC. (A DELAWARE CORPORATION) ARTICLE I OFFICES Section 1. Registered Office. The registered office of the corporation in the State of Delaware shall be as set forth in the Third Amended and Restated Certificate of Incorporation of the corporation, as the same may be amended or restated from time to time (the “Certificate of |
|
| January 23, 2024 |
EX-10.2 Exhibit 10.2 CGSH Comment October 27, 2023 DRAFT OCTOBER 6 2023 AMENDMENT TO ASSET PURCHASE AGREEMENT dated as of November 6, 2023 BY AND BETWEEN: BITMAIN TECHNOLOGIES DELAWARE LIMITED (as Vendor) - and - CORE SCIENTIFIC, INC. (as Purchaser) AMENDMENT TO ASSET PURCHASE AGREEMENT This AMENDMENT TO ASSET PURCHASE AGREEMENT (this “Amendment Agreement”), is made as of November 6, 2023 (the “Ex |
|
| January 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| January 23, 2024 |
EX-99.3 Exhibit 99.3 press release corescientific.com Core Scientific, Inc. Emerges from Chapter 11 with Strengthened Balance Sheet and Enhanced Competitive Position The Company maintains its position as one of the largest bitcoin miners in North America; Announces new Board of Directors AUSTIN, Texas, Jan. 23, 2024 – Core Scientific, Inc. (“Core Scientific” or the “Company”), a leader in bitcoin |
|
| January 17, 2024 |
Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE SOUTHERN DISTRICT OF TEXAS HOUSTON DIVISION § In re: § Chapter 11 § CORE SCIENTIFIC, INC., et al., § Case No. 22-90341 (CML) § Debtors1 § (Jointly Administered) § FOURTH AMENDED JOINT CHAPTER 11 PLAN OF CORE SCIENTIFIC, INC. AND ITS AFFILIATED DEBTORS (WITH TECHNICAL MODIFICATIONS) WEIL, GOTSHAL & MANGES LLP Clifford W. Carlson (24090024) |
|
| January 17, 2024 |
EX-99.T3C1 Exhibit T3C.1 CORE SCIENTIFIC, INC. AS ISSUER, THE GUARANTORS NAMED HEREIN AND WILMINGTON TRUST, NATIONAL ASSOCIATION, AS TRUSTEE AND COLLATERAL AGENT INDENTURE Dated as of January [●], 2024 10.00%/12.00% CASH/CASH-AND-PAYMENT IN STOCK CONVERTIBLE SECURED NOTES DUE 2029 CROSS-REFERENCE TABLE Reconciliation and tie showing the location in this Indenture of the provisions inserted pursuan |
|
| January 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2024 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40046 86-1243837 (State or other jurisdiction of incorporation) (Commission |
|
| January 17, 2024 |
Exhibit 99.2 press release corescientific.com Core Scientific, Inc. Plan of Reorganization Confirmed by Bankruptcy Court Following an oversubscribed Equity Rights Offering, the confirmed Plan clears the path for the Company’s emergence from Chapter 11 in the coming days AUSTIN, Texas, Jan. 16, 2024 – Core Scientific, Inc. (OTC: CORZQ) (“Core Scientific” or the “Company”), a leader in high-performa |
|
| January 17, 2024 |
T-3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM T-3 (Amendment No. 1) FOR APPLICATIONS FOR QUALIFICATION OF INDENTURES UNDER THE TRUST INDENTURE ACT OF 1939 Core Scientific, Inc. (Issuer) (Name of Applicants)* 210 Barton Springs Road, Suite 300 Austin, TX 78704 (Address of principal executive offices) Securities to be Issued under the Indenture to be Qualified Ti |
|
| January 17, 2024 |
EX-25.2 Exhibit 25.2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) WILMINGTON TRUST, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) 16-1486454 (I.R.S. employer identification no.) 1100 North Market Street Wilmington, DE 19890-0001 (Address of pr |
|
| January 17, 2024 |
Exhibit 99.3 IN THE UNITED STATES BANKRUPTCY COURT FOR THE SOUTHERN DISTRICT OF TEXAS HOUSTON DIVISION § In re: § Chapter 11 § CORE SCIENTIFIC, INC., et al., § Case No. 22-90341 (CML) § § (Jointly Administered) Debtors.1 § Re: Docket No. 1528, 1536, 1623, & 1685 § NOTICE OF FILING OF FOURTH AMENDED PLAN SUPPLEMENT IN CONNECTION WITH FOURTH AMENDED JOINT CHAPTER 11 PLAN OF CORE SCIENTIFIC, INC. AND |
|
| January 17, 2024 |
Exhibit 2.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE SOUTHERN DISTRICT OF TEXAS HOUSTON DIVISION United States Bankruptcy Court Southern District of Texas ENTERED January 16, 2024 Nathan Ochsner, Clerk § In re: § Chapter 11 § CORE SCIENTIFIC, INC., et al., § Case No. 22-90341 (CML) § Debtors1 § (Jointly Administered) § FINDINGS OF FACT, CONCLUSIONS OF LAW, AND ORDER (I) APPROVING DISCLOSURE S |
|
| January 17, 2024 |
EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) WILMINGTON TRUST, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) 16-1486454 (I.R.S. employer identification no.) 1100 North Market Street Wilmington, DE 19890-0001 (Address of pr |
